About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Core Insights - Canadian cannabis stocks are gaining attention as sector sentiment improves, with significant exposure to the U.S. market through brands and partnerships [1] - The U.S. cannabis industry is expanding, with total sales exceeding $32 billion annually and projections to surpass $50 billion by 2030, keeping Canadian operators relevant [1] - Renewed discussions on federal cannabis reform and regulatory changes are creating momentum for Canadian cannabis stocks, which often react sharply to U.S. policy developments [1] Company Summaries Tilray Brands (TLRY) - Tilray is a diversified cannabis and consumer products company with operations in cultivation, processing, and branded product distribution, expanding into beverages and wellness products for revenue stability [3][6] - The company has exposure to the U.S. market through hemp-derived products and THC offerings, with strategic partnerships enhancing national distribution [6] - Financially, Tilray is navigating a challenging environment with modest year-over-year revenue growth, unprofitability, and improved adjusted margins across segments [7] Canopy Growth (CGC) - Canopy Growth is a prominent Canadian cannabis producer with a broad portfolio of adult-use and medical brands, including flower, vapes, edibles, and infused beverages [8][10] - The company maintains indirect exposure to the U.S. market through affiliated entities, allowing participation in the U.S. THC market without direct federal conflict [10] - Recent financial results show operational improvement with increased quarterly revenue and reduced operating expenses, although profitability has not yet been achieved [11] Aurora Cannabis (ACB) - Aurora Cannabis focuses primarily on medical cannabis, operating cultivation and distribution facilities across multiple countries, including Europe and Australia [12][14] - The company has limited direct U.S. cannabis exposure but trades on NASDAQ, providing access for U.S. investors [14] - Recent financial results indicate progress toward stabilization, with increased medical cannabis revenue and improved gross margins, while maintaining solid cash reserves [15]

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.Shares of Lightwave Logic Inc (NASDAQ:LWLG) fell sharply in pre-market trading after the company announced pricing of $35 million public offering of common stock.Lightwave Logic shares dipped 14.5% to $3.22 in pre-market trading.Here are some other stocks moving lower in pre-market trading.Ascent Solar Technologies, Inc. (NASDAQ:ASTI) shares dipped 15.1% to $3.54 in pre-market trading after jumping 34% on Monday. ...

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.Shares of Lightwave Logic Inc (NASDAQ:LWLG) fell sharply in pre-market trading after the company announced pricing of $35 million public offering of common stock.Lightwave Logic shares dipped 14.5% to $3.22 in pre-market trading.Here are some other stocks moving lower in pre-market trading.Ascent Solar Technologies, Inc. (NASDAQ:ASTI) shares dipped 15.1% to $3.54 in pre-market trading after jumping 34% on Monday. ...

Core Viewpoint - Canopy Growth Corporation is making strategic moves to strengthen its position in the cannabis industry, particularly through the acquisition of MTL Cannabis Corp, while facing current stock price challenges [1][2][3]. Company Overview - Canopy Growth Corporation, listed on Nasdaq as CGC, is a significant player in the cannabis sector, involved in the production and sale of cannabis products for both medical and recreational markets [1]. - The company's current stock price is $1.66, reflecting a decrease of approximately 4.89% [3]. Recent Developments - Alliance Global Partners has adjusted its rating for Canopy Growth to Neutral and raised the price target from C$2 to C$2.50 following the announcement of the acquisition of MTL Cannabis Corp [2]. - The acquisition involves obtaining all issued and outstanding common shares of MTL Cannabis and settling associated debts, positioning Canopy Growth as a leading medical cannabis business in Canada [2]. Market Performance - Canopy Growth's stock has experienced significant volatility over the past year, with a high of $3.14 and a low of $0.77, and currently has a market capitalization of approximately $396.8 million [4]. - Today's trading volume for CGC is notably high, with 101,136,052 shares exchanged on the NASDAQ exchange [4].

Key Takeaways Weed stocks dropped Monday afternoon, reversing early gains on hopes President Trump could soon issue an executive order reclassifying marijuana. An expected reclassification from a Schedule I to a Schedule III drug would help companies in the sector reduce their taxes and relax banking restrictions. Weed stocks aren't flying so high anymore. Shares of Tilray Brands (TLRY) dropped nearly 5%, Canopy Growth (CGC) slipped 3%, and other cannabis stocks also lost ground in recent trading, reve ...

Canopy Growth Corporation ( CGC ) is the Canadian cannabis umbrella operation that grows and sells a range of cannabis, hemp, and cannabinoid-based products, largely by way of brands such as Tweed, DOJA, and 7 Acres. In addition, it ownsI focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Di ...

Within Canada’s tech sector, he said Celestica Inc. was impacted by some of the “AI skepticism.” Celestica shares finished 12.92% lower on the day, taking the most points off the index.Meanwhile, shares in Canada’s cannabis companies surged after reports that U.S. President Donald Trump is planning to ease federal restrictions on the drug.Shares of Tilray Brands Inc. gained 44.35%, while Canopy Growth Corp. shares were up 52.87%. Aurora Cannabis Inc. shares were up 19.04% and Organigram Global Inc. was up 1 ...

The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like heroin and LSD — cannabis is deemed to have no accepted medical use and high abuse potential. This status blocks research, interstate commerce, and access to basic banking services for operators. Meanwhile, 38 states have legalized medical marijuana, and 24 allow recreational use, creat ...

Key Takeaways President Donald Trump could reportedly issue an executive order to reclassify marijuana as a less dangerous substance as soon as Monday.The news sent shares of companies in the marijuana industry skyrocketing Friday. Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance. Tilray Brands (TLRY) was up close to 30% in recent trading, while Canopy Growth (CGC) shares jumped nearly 40%. (Read our daily markets cover ...